Jim Simons's position in Intellia Therapeutics is currently worth $286 Thousand. That's 0.00% of their equity portfolio (2812th largest holding). The first Intellia Therapeutics trade was made in Q2 2017. Since then Jim Simons bought shares seven more times and sold shares on seven occasions. The investor's estimated purchase price is $385 Thousand, resulting in a loss of 26%.